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Abstract
Background: Bronchiolitis obliterans (BO) is a fibrotic lung disease that occurs in a variety of clinical settings, including toxin
exposures, autoimmunity and lung or bone marrow transplant. Despite its increasing clinical importance, little is known
regarding the underlying disease mechanisms due to a lack of adequate small animal BO models. Recent epidemiological
studies have implicated exposure to diacetyl (DA), a volatile component of artificial butter flavoring, as a cause of BO in
otherwise healthy factory workers. Our overall hypothesis is that DA induces severe epithelial injury and aberrant repair that
leads to the development of BO. Therefore, the objectives of this study were 1) to determine if DA, delivered by intratracheal
instillation (ITI), would lead to the development of BO in rats and 2) to characterize epithelial regeneration and matrix repair
after ITI of DA.
Methods and Main Results: Male Sprague-Dawley rats were treated with a single dose of DA (125 mg/kg) or sterile water
(vehicle control) by ITI. Instilled DA resulted in airway specific injury, followed by rapid epithelial regeneration, and extensive
intraluminal airway fibrosis characteristic of BO. Increased airway resistance and lung fluid neutrophilia occurred with the
development of BO, similar to human disease. Despite rapid epithelial regeneration after DA treatment, expression of the
normal phenotypic markers, Clara cell secretory protein and acetylated tubulin, were diminished. In contrast, expression of
the matrix component Tenascin C was significantly increased, particularly evident within the BO lesions.
Conclusions: We have established that ITI of DA results in BO, creating a novel chemical-induced animal model that
replicates histological, biological and physiological features of the human disease. Furthermore, we demonstrate that
dysregulated epithelial repair and excessive matrix Tenacin C deposition occur in BO, providing new insights into potential
disease mechanisms and therapeutic targets.
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Introduction
Bronchiolitis obliterans (BO) is a fibrotic lung disease
characterized by narrowing and obliteration of the small
airways.[1] BO is most often recognized to occur in the setting
of lung or bone marrow transplantation, but has also been
described in the setting of occupational exposure to reactive
volatile chemicals.[2] Once BO occurs patients develop irre-
versible airflow obstruction that can progress to respiratory
failure, depending on the clinical context. BO is distinguished
from cryptogenic organizing pneumonia which involves intraal-
veolar and intraluminal airway fibrosis, often occurs after
infection, and frequently improves with treatment. Due to the
difficulty in confirming histological BO in the setting of lung or
bone marrow transplantation, the term bronchiolitis obliterans
syndrome (BOS) has been developed to identify patients with
presumed BO based on declining lung function in the absence of
other etiologies.[3,4] Despite the clinical importance of BO, little
is known about its pathogenesis, and there are no effective
treatments to reverse the airway fibrosis. The lack of intervention
and treatment strategies for BO can be attributed in part to the
limited availability of animal models in which to study disease
development. An overall goal of our research is to develop a
relevant rodent model of BO in which to further investigate
disease mechanisms.
Diacetyl (DA), the major volatile component of artificial butter
flavoring, has been associated with the development of airflow
obstruction and BO in workers in the microwave popcorn,
[5,6][7] flavoring[8], and diacetyl manufacturing industries[9].
Consistent with these clinical reports, acute DA inhalation in rats
was shown to cause inflammation and necrosis of the epithelium of
the nasal cavity and upper airways [10]. Similarly, we found that
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17644subacute or repeated inhalation of DA caused inflammation and
necrosis of the nasal passages of mice [11]. Although pulmonary
symptoms predominate in exposed workers, the nasal cavity was
the site of the most severe tissue damage in DA-exposed rats and
mice [5][10,11]. Interestingly, BO-like lesions did not develop in
either of these rodent inhalation models. Because rodents, unlike
humans, are obligate nose breathers, we believe that inhalation
leads to extensive absorption and reaction of DA in the nasal
cavity preventing penetration to the distal airways. In fact, inhaled
dosimetry and computational modeling studies performed with
DA vapor in the rat suggest that nasal and tracheal injury in the
rat might be predictive of intrapulmonary injury in mouth
breathing humans.[12]
Given these previous results, we hypothesized that bypassing the
nasal cavity by intratracheal instillation (ITI) of DA would lead to
the development of BO in rats. Although a non-physiological route
of exposure, ITI of chemicals, such as bleomycin, has proven to be
a very useful strategy for investigating mechanisms of toxicity to
the respiratory tract leading to fibrosis [13]. In order to test this
hypothesis we assessed histological, biological and physiological
measures and demonstrate the utility of instilled DA as a relevant
BO model. Furthermore, we hypothesized that ITI of DA induces
severe epithelial injury and aberrant repair that leads to the
development of BO. In order to test this hypothesis, we then
characterized serial chronological changes in airway epithelial cells
and matrix components from the time of DA exposure to the
development of BO. Using this approach, we have established that




All of the scientific data was performed with high technical,
scientific, and ethical standards. All use of vertebrate animals is
approved by the intramural National Institute of Health NIEHS
Animal Care and Use Committee (ACUC), NIEHS Assurance
number A4149-1. NIH guidelines are followed to ensure that
numbers of animals and animal care is appropriate, and that the
required measures are taken to limit animal discomfort, distress,
pain and injury. Methods of euthanasia and reason for selection
are consistent with the AVMA Guidelines on Euthanasia.
Veterinary care is provided by highly trained and experienced
staff.
Chemicals
DA (2,3-butanedione), CAS#431-03-8, was purchased from
Fluka Chemical Company (Milwaukee, WI) as a single lot number
1131562. The purity was $99.0%. Bradford reagent (CN 23208)
was purchased from Sigma-Aldrich (St. Louis, MO). LDH
Reagent kit (CN-L7572) was purchased from Pointe Scientific
(Canton, MI).
Animals
Male, Sprague-Dawley rats (295–305 g body weight) were
obtained from Charles River (Raleigh, NC). During a 5–10 day
acclimation, rats were weighed and randomized to treatment
groups. Animals were housed individually and provided with NIH-
31 chow and water ad libitum. Animal rooms were maintained with
a light-dark cycle of 12 h (light from 0700 to 1900 h). Body
weights were recorded on the day prior to treatment and 1, 3, and
7 days after treatment. Subgroups of animals were weighed and
euthanized (Nembutal, 60 mg/kg ip and pneumothorax) at 1, 3,
and 7 days after treatment for endpoint analysis as described in the
sections below.
Intratracheal Instillation
A mean body weight determined on study day 1 was used in
dose calculation. DA (188 mg/ml) was prepared in a ventilated
hood on the morning of dosing using sterile distilled water as the
vehicle. On study day 0, animals were lightly anesthetized
(isofluorane) and then intratracheally-instilled with DA (125 mg/
kg), or vehicle as a control. The volume instilled (200 ml) was the
same for all animals.
Pulmonary Function Assessment
Pulmonary function was measured invasively in a subset of rats
7 days after treatment with DA (n=8) or vehicle (n=4) using the
FlexiVent mechanical ventilator and data acquisition system
(SCIREQ, Montreal, PQ, Canada). Rats were anesthetized
(Nembutal, 60 mg/kg ip), a tracheal cannula inserted, and then
paralyzed with pancuronium bromide (0.82 mg/kg, ip). A
differential pressure transducer was connected to the tracheal
cannula and ventilation was maintained at a rate of 90 breaths/
minute, a tidal volume of ,8 ml/kg and a positive end expiratory
pressure of ,3 cm of water. For each rat, three total lung capacity
(TLC) maneuvers were performed to prevent atelectasis and to
maximize airway and alveolar recruitment prior to the initiation of
lung mechanics measurements which then cycled a total of 9 times
per animal. Values for total resistance (R), dynamic compliance
(C) and static compliance (Cst) obtained after each cycle were
averaged for each animal and these values were then averaged
within each experimental group.
Necropsy
At 1, 3, and 7 days after treatment, animals (n=6–9/group)
were euthanized (Nembutal, 60 mg/kg ip, pneumothorax) and the
lungs removed en bloc. The right bronchus was ligated and the right
lower (caudal) and accessory lobes were removed and placed in
cold RNAlater (Ambion, Austin, TX), then stored at 4uC until
RNA extraction. The left lung was then inflated with OCT (50%
OCT, 50% 0.9% saline). Sections of the left lung were placed in a
cryomold containing OCT, placed on dry ice and frozen for
immunofluorescence microscopy. Remaining segments of left lung
were fixed in 10% neutral-buffered formalin. The remaining right
upper (cranial) and middle lung lobes were inflated with 10%
neutral-buffered formalin, the bronchus ligated and the lobes
immersed in formalin. After 24 hours in formalin, the right lobes
and segments of left lung were transferred to 70% ethanol and
refrigerated until processed for light microscopy.
Bronchoalveolar lavage fluid (BALF) cell counts
Subgroups of rats (n=6) were euthanized 1, 3, and 7 days after
treatment with DA or vehicle and the lungs lavaged 3x with 10 ml
cold Ca
++,Mg
++-free Hanks balanced salts solution (BSS). The
BALF samples were centrifuged 5006 g for 10 minutes at 4uC.
The cell pellets from the 3 BALF samples were combined and the
total number of BAL cells/rat determined electronically (Coulter
ZB, Coulter Electronics, Inc., Marietta, GA). Cell differentials
were determined from manual cell counts of stained cytospin
preparations.
Histopathology
After fixation in 10% neutral-buffered formalin followed by
70% ethanol, sections of the right and left lungs were routinely
processed, embedded in paraffin, serial-sectioned at 5 mm and
Diacetyl-Induced Bronchiolitis Obliterans
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trichrome. The magnification of images was estimated by
multiplying the objective of the lens (10–40x) by the magnification
of the photomultiplier tube (10x) to provide the total magnifica-
tion. To evaluate cell proliferation, subgroups of animals (n=12)
were pulse-dosed with 50 mg/kg (0.5 ml ip) bromodeoxyuridine
(BrdU) 4 hours prior to euthanasia. A section of duodenum was
included in each cassette to confirm systemic delivery of BrdU to
the animal.
The presence of BO was defined by airway obstruction due to
intraluminal polypoid fibrosis or concentric fibrosis within the
airway wall. To determine the extent of BO among DA treated
Table 1. Effect of Diacetyl on Airway Fibrosis.







Day 3 diacetyl 7/9 0–9 1.060.2 0.02
vehicle 0/6 0 060
Day 7 diacetyl 9/9 6–23 3.060.3 0.004
vehicle 0/6 0 060
a Number of rats with lesions/number evaluated.
b Range of lesions.
c Mean 6 SE.
d diacetyl vs. vehicle control, Wilcoxon sign rank test.
doi:10.1371/journal.pone.0017644.t001
Figure 1. Progression of epithelial injury to bronchiolitis obliterans after diacetyl instillation. a, Bronchiole of a control rodent 7 days
post instillation, showing normal airway epithelium and structure (H&E, 200x). b, Bronchiole of a diacetyl- (DA-) treated rodent 1 day after instillation
showing epithelial sloughing (arrows) and peribronchiolar inflammation (arrowhead) (H&E,100x). c, Bronchus of DA-treated rodent 3 days after
instillation showing regenerating epithelium with mild hyperplasia (arrow), (H&E, 200x). d, Bronchiole of DA-treated rodent 3 days after instillation
showing fibrosis (arrow) in area of epithelial erosion, regenerating epithelium in bottom portion of bronchiole (arrowheads), and mixed intraluminal
inflammation (H&E, 100x). e, BO in a bronchiole characterized by polypoid intraluminal fibrosis and peribronchiolar inflammation (H&E, 100x). f,
Bronchiole with concentric intramural fibrosis, typical of constrictive BO (H&E, 100x). g,h, Advanced BO lesion with nearly complete airway
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fibrotic lesions was assessed at days 3 (9 rodents/group) and 7 (9
rodents in DA, 6 in control group). Bronchial and bronchiolar
fibrosis was graded in a semi-quantitative manner by an
experienced lung pathologist. The designation of intraluminal or
intramural bronchial and bronchiolar fibrosis was based upon the
predominant location of the lesion (e.g. primarily within the lumen
or primarily within the wall of the airway) and scored as follows:
1–5 lesions =1+, 6–10 lesions =2+, 11–15 lesions =3+, and .15
lesions =4+. The score reflects only bronchial or bronchiolar
fibrosis and not fibrosis of the alveolar ducts, alveolar spaces or
alveolar walls. Although all lobes of the right and left lung have
been examined in different experiments and have contained BO
lesions, the fibrosis score in the current study was based solely
upon representative sections of the left lung and upper and middle
lobes of the right lung since the remainder of lung tissue was used
for fluorescent stains or RNA analysis.
Immunofluorescence
Sections of lung were frozen (left) or formalin fixed (right and
left) at necropsy. Frozen tissue was preserved at 280uC until
cryosectioned at 6 mm. Sections were stored at 280uC until
stained. Formalin fixed paraffin embedded tissue was serial-
sectioned at 5 mm and the slides stored at room temperature until
stained.
Primary Antibodies: Rabbit anti-rat Clara cell secretory protein
(CCSP) antibody (1:20,000; gift from Barry Stripp), mouse IgG2b
anti-acetylated tubulin (AcT) antibody (1:24,000, Sigma, St Louis,
MO), mouse IgG2a anti-smooth muscle actin (SMA) antibody
(1:500, Sigma, St Louis, MO), mouse IgG1 anti-BrdU antibody








Total Cells vehicle 4.9161.72 4.2361.95 5.8460.89
diacetyl 9.4262.59* 8.7162.36* 5.1461.30
Macrophages vehicle 3.8161.42 4.1662.03 5.8460.89
diacetyl 6.3162.16* 5.2861.68 4.0362.10
Neutrophils vehicle 0.8961.00 0.0660.08 0.0060.00
diacetyl 3.1060.24* 3.0761.12* 1.1161.46*
a5–9 animals/group.
bMean cell number (x10
6) 6 SD.
*Significantly different (p,0.05) from respective controls.
doi:10.1371/journal.pone.0017644.t002
Figure 2. Altered Lung Function in Diacetyl-treated Rats. Pulmonary function was evaluated 7 days after treatment with diacetyl (DA) or water
(control). a, Airway resistance (R), was significantly increased (**p,0.01) in DA-treated rats, relative to controls. b,c, Both dynamic (C) and static (Cst)
compliance were significantly decreased (***p,0.001) in DA-treated rats, relative to controls.
doi:10.1371/journal.pone.0017644.g002
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(1:200, Santa Cruz Biotechnology, Santa Cruz, CA). Secondary
antibodies: Alexa Fluor 594 Donkey anti-Rabbit IgG, Alexa Fluor
488 Goat anti-mouse IgG2b, Alexa Fluor 488 Goat anti-mouse
IgG2a, and AlexaFluor 488/594 Goat anti-mouse IgG1 (1:500,
Invitrogen, Carlsbad, CA). Sections were blocked with 5% BSA in
phosphate-buffered saline (PBS) for non-specific antigen reactivity
following citrate buffer retrieval. Primary and secondary antibod-
ies were diluted in blocking solution and incubated overnight at
4uC or room temperature for 90 minutes, respectively. Slides were
extensively washed in PBS and cover-slipped with DAPI (Sigma,
St Louis, MO) in Fluoromont G mounting media (Southern
Biotech, Birmingham, AL). Images were obtained using an
Olympus Provis AX70 microscope (Center Valley, PA) equipped
with a digital camera and processed using Image-Pro Plus (Media
Cybernetics, Silver Spring, MD).
Whole lung transcript expression
Each analysis at the various time points represents a minimum
of 6 separate animals in treated vs. control groups. For
transcriptional analysis, the caudal and accessory lobes of the
right lung were placed into RNAlater
TM. RNA isolation was
performed using the RNAqueous-4PCR kit (Ambion, Austin,
TX) and quantified by a spectrophotometer (260/280) (Nano-
Drop products, Wilmington, DE). Quality was assessed by the
Bio-Rad Experion bioanalyzer (Bio-Rad, Hercules, CA). RNA
was reverse transcribed into cDNA using the high capacity
reverse transcription kit (ABI, Foster City, CA). Transcripts for
genes of interest (Clara Cell Secretory protein, surfactant protein
C, collagen 1alpha-1, and Tenascin C) were assessed using 40 ng
of cDNA in each assay of Taqman realtime PCR using validated
Taqman probe and primer combinations (ABI, Foster City, CA);
each assay was performed in triplicate. Cycle conditions were:
95uC for 10 minutes, and 40 cycles of 95uC for 15 seconds and
60uC for 1 minute. RT-PCR for target transcripts and
endogenous transcripts (b actin) were performed in multi-plex
using Fam-labeled target probes, and VIC-labeled endogenous
probes. Ct values were determined using an ABI 7500 RealTime
PCR System (ABI, Foster City, CA) with SDS software version
1.3.1. Fold change was determined by comparing DA dCt values




Changes in BAL fluid cell counts were determined by 1-way
ANOVA and Tukey’s multiple comparison test. For analysis of
bronchial and bronchiolar fibrosis score and pulmonary function
parameters (R, C and Cst) unpaired Student’s t tests were used.
For analysis of transcript data, non parametric t-tests were used
to compare differences among means in two independent
groups. All of these analyses were performed using PrismGraph-
Pad 5. P-values of less than 0.05 were considered statistically
significant.
Figure 3. Diacetyl exposure results in early epithelial loss of
CCSP transcript followed by collagen deposition. Whole lung
transcript analysis using real-time PCR mRNA levels from rodents
treated with water or diacetyl (DA). At each time-point (day 1, 3, and 7)
DA-treated rodents were all compared to their appropriate water
treated counterparts. a, CCSP transcript is significantly down-regulated
at days 1,3, and 7. b, SPC transcript is minimally affected 1 day post DA
treatment, and recovers to expression levels similar to water control at
days 3 and 7. c, Collagen 1a-1 transcript is significantly up-regulated at
days 3 and 7 post DA treatment, consistent with BO histology.
doi:10.1371/journal.pone.0017644.g003
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DA treated animals develop histopathological changes
characteristic of BO
All of the DA treated rodents, but none of the controls,
developed bronchial and bronchiolar fibrotic lesions. These foci of
airway fibrosis were present in major bronchi as well as in
bronchial branches and bronchioles. When all lobes were
examined across multiple experiments, the lesions were more
numerous in the left lung and in the right lower and accessory
lobes than in the right upper and middle lobes. As shown in
Table 1, using a semi-quantitative scoring system that reflects the
extent of bronchial and bronchiolar lesions, BO developed
consistently among all the day 7 DA-treated rodents but not in
the vehicle-treated animals and increased in severity from day 3 to
day 7 after DA treatment (bronchial and bronchiolar fibrosis score
at day 7 in DA-treated rodents vs. vehicle controls, 3.060.33 vs.
060, respectively, p value =0.004).
Figure 1 shows the progression of epithelial injury leading to
BO. In contrast to a vehicle-treated control airway (Figure 1a), ITI
of DA resulted in severe necrosis and sloughing of the bronchial
and bronchiolar epithelium by day 1 (Figure 1b). Mixed
populations of inflammatory cells, including histiocytes, lympho-
cytes, eosinophils, and neutrophils were present in and around
bronchi with epithelial necrosis. By day 3, evidence of regenerating
epithelium was present with moderate epithelial hyperplasia in
some airways and frequently a surrounding adventitial wreath of
mononuclear cells composed of histiocytes and lymphocytes
(Figure 1c). In addition, by day 3, areas of polypoid intraluminal
airway fibrosis were evident in association with regions of epithelial
erosion (Figure 1d). At this stage, the intraluminal fibrosis had a
loose, myxoid appearance. By day 7, more extensive airway
fibrosis accompanied by a mixed inflammatory infiltrate was
evident, resulting in partial obstruction of airways either by
intraluminal polypoid growths (Figure 1e) or by intramural
(constrictive or circumferential) fibrosis (Figure 1f). A few airways
exhibited virtually complete obstruction of lumens by dense
fibrous tissue (Figure1g) with a prominent collagenous component
evident on the Masson Trichrome stain (Figure 1h).
Increased neutrophilia occurs in the lung fluid of DA-
treated animals
The total number of BAL cells increased significantly 1 and 3
days after ITI DA, but returned to levels comparable to controls
Figure 4. Severe epithelial injury with loss of normal epithelial structure occurs one day after Diacetyl treatment. a, d, Co-
immunodetection of CCSP (red), and acetylated tubulin (AcT), (green). b, e, Co-immunostained for CCSP (red), and SMA (green). c, f, Co-
immunostained for CCSP (red) and b-catenin (green). DAPI, a nuclear counter-stain, is shown in blue. Airways from control rodents (a,b,c) show
baseline expression in controls of CCSP, AcT, SMA, and b-catenin (200x). CCSP and AcT (a) are expressed throughout a small airway, with a thin layer
of SMA (b) surrounding the airway. The b-catenin staining shows membrane associated expression (c). Airways from DA-treated rodents one day
following exposure (d, e, f) demonstrate severe depletion of epithelial protein expression of CCSP, AcT (d), and b-catenin (f), (400x). The b-catenin
staining (f) also illustrates a flattened post injury cellular structure.
doi:10.1371/journal.pone.0017644.g004
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elevated at days 1, 3, and 7 in DA-treated rodents as compared to
controls. The numbers of alveolar macrophages were significantly
greater than controls only at day 1.
DA-treated animals develop abnormal lung function
consistent with severe small airways disease
DA-treated animals as compared to controls demonstrated
significant changes in pulmonary function at Day 7. Airway
resistance (R) was significantly increased (p,0.01) in DA-treated
rodents relative to controls (Figure 2a). As shown in Figures 2b
and 2c, both dynamic (p,0.001) and static compliance (p,0.001)
were significantly decreased in DA-treated rodents relative to
controls.
DA treated animals develop an epithelial specific pattern
of injury with fibrosis
Whole lung transcript analysis, as shown in Figure 3a,
demonstrates a significant depletion of the epithelial transcript
CCSP, a marker present exclusively in the non-ciliated Clara
cells, showing a 1.8-fold down regulation (p=0.005), at day 1.
Furthermore, depletion of CCSP transcripts persisted through
day 3 (1.7 fold down-regulation, p=0.02) and day 7 (1.7 fold
down regulated, p=0.003) after DA exposure. In contrast, levels
of surfactant protein-C (SPC) present in alveolar cells
(Figure 3b), demonstrated only minimal down-regulation (1.2
fold down-regulated, p=0.18) at day 1, and transcript levels
returned to control levels at days 3 and 7, thus confirming a
pattern of injury specific to the airway epithelium and not the
parenchymal tissue. Figure 3c shows collagen 1a-1 transcript
was up-regulated 1.74-fold (p=0.043) at day 3, with an even
greater 2.6-fold increase at day 7 (p=0.0007), as compared to
controls, consistent with the observed airway fibrosis in
Figure 1e-h.
DA induces rapid and severe loss of the normal airway
epithelium
Immunohistochemical stains for CCSP, acetylated tubulin
(AcT), smooth muscle actin (SMA), and b-catenin of control
rodents show the normal distribution of airway epithelial cell
types, normal columnar membrane expression of b-catenin, and
minimal bronchiolar smooth muscle (Figure 4a–c). One day
following ITI of DA, only small remnants of the normal epithelium
remained with a few cells present expressing CCSP, AcT, or b-
catenin (Figure 4d–f). Furthermore, the epithelial remnants in
Figure 4f appear flattened and with suggestive intracellular, rather
than junctional, staining of b-catenin (Figure 4f).
Airway epithelium proliferates after DA treatment
BrdU staining demonstrated rapid regeneration of the bronchial
and bronchiolar epithelium in DA-treated rodents. Although
minimal BrdU staining was evident in both groups at day 1 (data
not shown), by day 3 the airway epithelium of DA-treated rodents
demonstrated extensive increased proliferation, not seen in the
vehicle controls, (Figures 5a–c). Interestingly, evidence of
increased BrdU activity was also evident within the regions of
intraluminal polypoid fibrosis at day 3 (Figure 5c), but not present
at day 7, in the setting of an advanced nearly obliterated airway
(Figure 5d).
Aberrant airway epithelial cell regeneration occurs in BO
Immunohistochemical stains for CCSP, AcT, SMA, and b-
catenin of control rodents show the normal distribution of airway
epithelial cell types with a majority of cells expressing CCSP or
AcT, normal junctional expression of b-catenin, and with minimal
airway SMA (Figure 6a–c). In contrast, in a minimally affected
airway of a representative early (day 3) lesion (Figure 6d–f),
expression of both CCSP and AcT were diminished as compared
to controls despite relatively normal appearing epithelial junctional
Figure 5. Regeneration of injured epithelium after diacetyl instillation. a, b, c, d, Co-immunodetection of CCSP (red) and BrdU (green), with
DAPI, a nuclear counter-stain (blue). a, An airway from a control rodent at day 3 shows expected distribution of CCSP with no BrdU detection (100x).
b, An early lesion from a rodent treated with diacetyl (DA) shows significant epithelial regeneration detected by BrdU by day 3 (200x). c, A moderate
BO lesion seen at day 3 after DA exposure shows significant BrdU staining along the epithelium as well as within the fibrotic lesion (arrow) (200x). As
seen in b and c, regions of regeneration do not co-localize with epithelial CCSP staining. d, In an advanced BO lesion at day 7, CCSP distribution
remains abnormal and diminished as compared to normal, and regeneration is also diminished (200x).
doi:10.1371/journal.pone.0017644.g005
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with severely obliterated airway, b-catenin expression, although
disorganized, was present covering regions of intraluminal fibrosis
(Figure 6i). In contrast, there is almost no CCSP or AcT
expression within the epithelium (Figure 6g,h). In addition, SMA
labeling shows focal staining suggestive of myofibroblasts in areas
of active intraluminal fibrosis, and bronchiolar SMA that appears
more abundant and disorganized than in controls (Figure 6h).
DA induced BO is characterized by excessive matrix
deposition of Tenascin C
Transcript expression of the matrix component Tenascin C
(Tn-C) was up-regulated at all three time points tested after DA
exposure, and significantly so at days 3 (2.07-fold, p=0.008) and 7
(2.64-fold, p=0.018) as compared to controls (Figure 7a).
Immunohistochemical staining confirmed intraluminal Tn-C
protein expression in airways 3 and 7 days following DA exposure.
Small airways with active BO demonstrated accumulation of Tn-
C expression within early intraluminal polypoid lesions (Figure 7b),
and diffusely throughout advanced BO lesions (Figure 7c).
Discussion
We present a novel chemical-induced rodent model of BO using
ITI administration of DA and demonstrate that this model
replicates physiological, biological and pathological features of
human BO. Within seven days after a single high-dose DA
exposure, rats develop increased airway resistance, increased BAL
neutrophilia, and airway fibrosis and histopathology characteristic
of BO. In contrast to other rodent models used to study BO such
as heterotopic tracheal transplantation, in our model airway
fibrosis develops in the setting of a fully vascularized and aerated
lung parenchyma[15]. This easily reproducible and clinically
relevant model should advance our understanding of the
pathogenesis and potential treatment of BO.
DA was selected to model the development of BO given the
strong clinical and epidemiological associations between workplace
exposuretoDAand BO.Inpreviousstudies,rodents exposedtoDA
by inhalation failed to develop BO-like lesions, although extensive
necrosis occurred in the nasal cavities of treated rats and mice
[10,11]. Because rodents are obligate nose breathers, we hypoth-
esized that the extensive absorption and reaction of DA in the nasal
cavity prevents toxic concentrations of DA from reaching the distal
airways when delivered by inhalation, consistent with previous
dosimetry studies in rats treated with DA vapor.[12] In addition,
intratracheal administration of other chemical agents, such as nitric
acid or gastric contents, has been associated with bronchiolar
changes in rat and canine models.[16,17] Therefore, in order to
bypass the nasal cavity, DA was administered by ITI in the current
study. Although this model is useful for investigating the
pathogenesis of BO, given the nonphysiological route of adminis-
tration, our results may have limited use for human risk assessment.
Figure 6. Injured epithelium regenerates, shows abnormal cellular composition, and progresses to BO. a, d, g, show co-
immunodetection of CCSP (red) and acetylated tubulin (AcT) (green). b, e, h, are co-immunostained for CCSP (red), and SMA (green). c, f, i, are co-
immunostained for CCSP (red) and b-catenin (green). DAPI, a nuclear counter-stain, is shown in blue. a, b, c, represent an airway from a control rodent
(200x). d, e, f, represent an early lesion from a DA-treated rodent 3 days after instillation (200x). g, h, i represent an advanced lesion airway from a DA-
treated rodent 7 days after instillation (400x). Three days after DA, the b-catenin expression appears normal, showing that epithelial repopulation has
occurred (f), but CCSP and AcT expression is markedly diminished (d, e) demonstrating that the repopulated epithelium does not exhibit the normal
airway cellular composition. Similar to day 3, the advanced day 7 BO lesion also shows a loss of CCSP and AcT expression; however, b-catenin
expression is also irregular reflecting the distorted epithelium overlying the intraluminal polypoid lesions.
doi:10.1371/journal.pone.0017644.g006
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of high-dose DA will cause BO in rodents. In contrast, human
studies suggest that BO develops in factory workers exposed to DA
or other volatile components of artificial butter flavorings as a
result of constant or intermittent inhalational exposure to
considerably lower concentrations of vapors. We are actively
pursing additional studies in rodents to better characterize the
long-term effects of inhaled DA at various concentrations as well
as ITI of other related compounds present in the flavoring mix.
These inhalation studies could provide a direct biological link
between current workplace DA exposures and the development of
human BO.
Several features of our model are particularly notable and
closely parallel human BO. The hallmark lesion of BO, small
airway fibrosis, was observed in all DA-treated animals. The
presence of fibrosis was confirmed with increased trichrome
staining in the lesions and significantly increased collagen
transcripts within the lung. In addition, the physiological airflow
measurements provide another strong biological link to human
disease. A clinical diagnosis of BO is characterized by obstructive
physiology with a reduced FEV1 (forced expiratory volume in 1
second). Although FEV1 cannot be measured in rats, measure-
ments of increased airway resistance and decreased compliance
are accepted indicators of airway obstruction in rodents.[18] In
the setting of DA induced BO we observed significantly increased
airway resistance and decreased compliance. Given the normal
appearance of most of the lung parenchyma and airway specific
pattern injury observed with DA exposure these results would
suggest that most of the airways were affected and at least partially
occluded in the DA treated animals. Since the small airways in
normal lungs only make a minimal contribution to total airway
resistance the significant changes observed in this study could only
occur with very extensive small airway disease.
Furthermore, neutrophilic airway inflammation in this model
also parallels that described in human BO. Neutrophilic
inflammation has been reported in microwave popcorn factory
workers with obstructive lung disease in association with the
development of other indices of pulmonary inflammation [19].
Increased neutrophils in the lung fluid also have been extensively
described in the setting of transplant related BO [20,21].
Additional studies are needed to clarify the extent to which
neutrophils participate in the development of inflammatory injury
to the airway epithelium, degradation of the basement membrane,
or fibroblast activation in the setting of DA-induced BO.
Although precise mechanisms that lead to the development of
DA-induced BO are uncertain, several intriguing findings are
apparent from our results. First, BO appears to result from an
initial severe injury to the lower airway epithelium by this highly
reactive chemical. DA is a strong electrophile and would be
expected to readily react with thiols and amines on cellular
proteins. Damage to membrane proteins by DA could compro-
mise membrane integrity resulting in loss of the airway epithelium.
In some early lesions we observed sloughing of intact epithelial
cells, suggesting that DA may specifically affect epithelial
attachment sites with or without necrosis of epithelial cells. In
either case, loss of the overlying epithelium and disruption of the
basement membrane could be prerequisites for airway fibrosis. For
example, one plausible mechanism would involve severe epithelial
injury leading to exposed fibrous lamina propria, allowing
fibroblast precursors to migrate from the ulcerated airway wall
into the lumen.
A very striking and novel observation is that despite rapid
epithelial regeneration after DA injury the airway cellular
composition remains abnormal. We demonstrated a marked
Figure 7. Tenascin-C transcript and protein is up-regulated
after diacetyl treatment. Real-Time PCR showing mRNA levels
derived from total whole lung RNA from rodents treated with water or
diacetyl (DA). At each time-point (day 1, 3, and 7) DA-treated rodents
were all compared to their appropriate control counterparts. a, Tn-C
transcript is significantly up-regulated at days 3 and 7, following DA
exposure. b, c, Images show co-immunodetection for Tn-C (red), and
SMA (green). DAPI, a nuclear counter stain, is shown in blue. b, An early
day 3 lesion of a medium-sized affected airway shows Tn-C expression
within an area of active intraluminal fibrosis, while SMA is predomi-
nately detected in the wall of the airway (200x). A larger airway, c,
representing an advanced day 7 lesion also shows Tn-C deposition
throughout the fibrotic BO lesion (200x).
doi:10.1371/journal.pone.0017644.g007
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apparent epithelial regeneration. Furthermore we confirm deple-
tion of CCSP transcript at all time points tested after DA exposure.
These changes might simply reflect part of the normal process of
epithelial repair and a failure of newly differentiated epithelium to
express normal cellular markers. Alternatively, aberrant epitheli-
um cellular composition might contribute directly to the
development of intraluminal fibrosis, perhaps through an inability
of the newly regenerated epithelium to limit fibroblast activity.
Additional research is needed to determine if disruption of the
airway epithelial layer is also integral to the pathogenesis of BO in
DA-exposed workers or transplant recipients.
Given that a subset of CCSP expressing epithelial cells have
been implicated to function as progenitor cells critical for normal
repair of the lower airway epithelium, the sustained depletion of
these cells, in particular, could contribute to disease pathogenesis
[22]. A plausible hypothesis, consistent with our results, would be
that the loss of Clara cells with their progenitor capacity
contributes to aberrant local epithelial repair mechanisms that
lead to the development of BO. Further studies are needed to
determine if the loss of CCSP actively contributes to BO, or is
simply a consequence of the disease development. In either case,
these findings provide another strong parallel between our model
and human BO, as a depletion of CCSP has been reported in the
blood or lung fluid of lung or bone marrow transplant recipients
with BO [23,24].
Another novel observation of our study is the upregulation of
Tn-C both at a transcript and protein level in BO. Tn-C is a
matrix protein that has recently been identified to accumulate in
several inflammatory and fibrotic lung conditions. For example,
increased Tn-C has been reported in the airway walls of human
asthmatic patients and in murine models of asthma [25,26].
Furthermore, Tn-C deficient mice have reduced airway
hyperreactivity, cell recruitment and inflammatory cytokines
after ovalbumin asthma challenge, suggesting a role for this
matrix protein in the promotion of lung inflammation [27].
Finally, up-regulation of this matrix protein was recently
reported in a murine model of aberrant epithelial repair [28].
In these studies, naphthalene exposure was used as a model of
productive or successful epithelial repair and contrasted with
persistent (non-productive) Clara cell injury occurring as a result
of ganciclovir administration to transgenic mice (CCtk) express-
ing herpes simplex virus thymidine kinase (HSV-tk). In the case
of naphthalene, early increased Tn-C levels returned to normal
within 6 days of injury, while in the case of the persistent injury
model, Tn-C transcript levels continued to rise at later time
points, with a peribronchial pattern of distribution. BO,
however, was not observed in that model despite the increased
Tn-C perhaps due to less severe injury or fundamental
differences in airway response to injury among different rodent
species. Collectively these data support further studies to
determine if Tn-C actively participates in the development of
bronchiolar obliteration in DA induced BO, perhaps through
interactions with the epithelium or fibroblasts.
In summary, we have demonstrated that ITI of DA replicates
biological, physiological and histological features of human BO.
There are currently no other rodent models that replicate these
features of human BO in the setting of fully vascularized aerated
lung parenchyma. Using this model, we demonstrate that BO is
characterized by dysregulated epithelial repair with loss of normal
airway cellular composition. In addition, we demonstrate for the
first time that BO involves aberrant matrix deposition of Tn-C,
localized within the airway fibrotic lesions. These results provide a
novel model in which mechanisms of injury leading to BO can be
further elucidated, and in which plausible targets are identified to
develop new therapeutic strategies.
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